The Indian Institute of Technology (IIT), Guwahati, is collaborating with Ahmedabad-based animal healthcare company Hester Biosciences to develop a vaccine against Covid-19. It expects the vaccine to be ready for animal studies by the end of this year.
The vaccine is planned to be based on the recombinant avian paramyxovirus-based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2, and that will be a vaccine candidate for further study.
The avian paramyxovirus-1 has been explored as a vaccine vector for various animals and human pathogens and used to express the immunogenic protein of

)